The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients

Hugo ten Cate; Anthonie W. A. Lensing; Jeffrey I. Weitz; Saskia Middeldorp; Jan Beyer-Westendorf; Dagmar Kubitza; Timothey Brighton; Gary E. Raskob; Patrick Mismetti; Paolo Prandoni; Martin Gebel; Martin H. Prins

doi:10.1016/j.thromres.2018.08.008

The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients

Hugo ten Cate, Anthonie W. A. Lensing, Jeffrey I. Weitz, Saskia Middeldorp, Jan Beyer-Westendorf, Dagmar Kubitza, Timothey Brighton, Gary E. Raskob, Patrick Mismetti, Paolo Prandoni, Martin Gebel, Martin H. Prins

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	75-83
Number of pages	9
Journal	Thrombosis Research
Volume	170
DOIs	https://doi.org/10.1016/j.thromres.2018.08.008
Publication status	Published - 1 Oct 2018

Keywords

DEEP-VEIN THROMBOSIS
XA INHIBITOR RIVAROXABAN
ORAL RIVAROXABAN
EINSTEIN-DVT

Access to Document

10.1016/j.thromres.2018.08.008

Cite this

ten Cate, H., Lensing, A. W. A., Weitz, J. I., Middeldorp, S., Beyer-Westendorf, J., Kubitza, D., Brighton, T., Raskob, G. E., Mismetti, P., Prandoni, P., Gebel, M., & Prins, M. H. (2018). The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients. Thrombosis Research, 170, 75-83. https://doi.org/10.1016/j.thromres.2018.08.008

ten Cate, Hugo ; Lensing, Anthonie W. A. ; Weitz, Jeffrey I. ; Middeldorp, Saskia ; Beyer-Westendorf, Jan ; Kubitza, Dagmar ; Brighton, Timothey ; Raskob, Gary E. ; Mismetti, Patrick ; Prandoni, Paolo ; Gebel, Martin ; Prins, Martin H. / The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients. In: Thrombosis Research. 2018 ; Vol. 170. pp. 75-83.

@article{c05fde43d1cd4d7ca28a05d849dcbf88,

title = "The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients",

keywords = "DEEP-VEIN THROMBOSIS, XA INHIBITOR RIVAROXABAN, ORAL RIVAROXABAN, EINSTEIN-DVT",

author = "{ten Cate}, Hugo and Lensing, {Anthonie W. A.} and Weitz, {Jeffrey I.} and Saskia Middeldorp and Jan Beyer-Westendorf and Dagmar Kubitza and Timothey Brighton and Raskob, {Gary E.} and Patrick Mismetti and Paolo Prandoni and Martin Gebel and Prins, {Martin H.}",

year = "2018",

month = oct,

day = "1",

doi = "10.1016/j.thromres.2018.08.008",

language = "English",

volume = "170",

pages = "75--83",

journal = "Thrombosis Research",

issn = "0049-3848",

publisher = "Elsevier Science",

}

ten Cate, H, Lensing, AWA, Weitz, JI, Middeldorp, S, Beyer-Westendorf, J, Kubitza, D, Brighton, T, Raskob, GE, Mismetti, P, Prandoni, P, Gebel, M & Prins, MH 2018, 'The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients', Thrombosis Research, vol. 170, pp. 75-83. https://doi.org/10.1016/j.thromres.2018.08.008

The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients. / ten Cate, Hugo; Lensing, Anthonie W. A.; Weitz, Jeffrey I.; Middeldorp, Saskia; Beyer-Westendorf, Jan; Kubitza, Dagmar; Brighton, Timothey; Raskob, Gary E.; Mismetti, Patrick; Prandoni, Paolo; Gebel, Martin; Prins, Martin H.

In: Thrombosis Research, Vol. 170, 01.10.2018, p. 75-83.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients

AU - ten Cate, Hugo

AU - Lensing, Anthonie W. A.

AU - Weitz, Jeffrey I.

AU - Middeldorp, Saskia

AU - Beyer-Westendorf, Jan

AU - Kubitza, Dagmar

AU - Brighton, Timothey

AU - Raskob, Gary E.

AU - Mismetti, Patrick

AU - Prandoni, Paolo

AU - Gebel, Martin

AU - Prins, Martin H.

PY - 2018/10/1

Y1 - 2018/10/1

KW - DEEP-VEIN THROMBOSIS

KW - XA INHIBITOR RIVAROXABAN

KW - ORAL RIVAROXABAN

KW - EINSTEIN-DVT

U2 - 10.1016/j.thromres.2018.08.008

DO - 10.1016/j.thromres.2018.08.008

M3 - Article

C2 - 30121419

VL - 170

SP - 75

EP - 83

JO - Thrombosis Research

JF - Thrombosis Research

SN - 0049-3848

ER -